Literature DB >> 20936840

Immunoaffinity enrichment and liquid chromatography-selected reaction monitoring mass spectrometry for quantitation of carbonic anhydrase 12 in cultured renal carcinoma cells.

Agnes Rafalko1, Othon Iliopoulos, Vincent A Fusaro, William Hancock, Marina Hincapie.   

Abstract

Liquid chromatography-selected reaction monitoring (LC-SRM) is a highly specific and sensitive mass spectrometry (MS) technique that is widely being applied to selectively qualify and validate candidate markers within complex biological samples. However, in order for LC-SRM methods to take on these attributes, target-specific optimization of sample processing is required, in order to reduce analyte complexity, prior to LC-SRM. In this study, we have developed a targeted platform consisting of protein immunoaffinity enrichment on magnetic beads and LC-SRM for measuring carbonic anhydrase 12 (CA12) protein in a renal cell carcinoma (RCC) cell line (PRC3), a candidate biomarker for RCC whose expression at the protein level has not been previously reported. Sample processing and LC-SRM assay were optimized for signature peptides selected as surrogate markers of CA12 protein. Using LC-SRM coupled with stable isotope dilution, we achieved limits of quantitation in the low fmol range sufficient for measuring clinically relevant biomarkers with good intra- and interassay accuracy and precision (≤17%). Our results show that using a quantitative immunoaffinity capture approach provides specific, accurate, and robust assays amenable to high-throughput verification of potential biomarkers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20936840      PMCID: PMC3046293          DOI: 10.1021/ac101981t

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  28 in total

Review 1.  The human plasma proteome: history, character, and diagnostic prospects.

Authors:  N Leigh Anderson; Norman G Anderson
Journal:  Mol Cell Proteomics       Date:  2002-11       Impact factor: 5.911

Review 2.  Mass spectrometry-based proteomics.

Authors:  Ruedi Aebersold; Matthias Mann
Journal:  Nature       Date:  2003-03-13       Impact factor: 49.962

3.  Analysis and isolation of human transferrin receptor using the OKT-9 monoclonal antibody covalently crosslinked to magnetic beads.

Authors:  G B Karlsson; F M Platt
Journal:  Anal Biochem       Date:  1991-12       Impact factor: 3.365

4.  A secreted glycoprotein induced by estrogen in human breast cancer cell lines.

Authors:  B Westley; H Rochefort
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

Review 5.  Cathepsin D in breast cancer.

Authors:  H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1990-07       Impact factor: 4.872

6.  Unique scanning capabilities of a new hybrid linear ion trap mass spectrometer (Q TRAP) used for high sensitivity proteomics applications.

Authors:  J C Yves Le Blanc; James W Hager; A M Patricia Ilisiu; Christie Hunter; Feng Zhong; Ivan Chu
Journal:  Proteomics       Date:  2003-06       Impact factor: 3.984

7.  Cleavage N-terminal to proline: analysis of a database of peptide tandem mass spectra.

Authors:  Linda A Breci; David L Tabb; John R Yates; Vicki H Wysocki
Journal:  Anal Chem       Date:  2003-05-01       Impact factor: 6.986

Review 8.  Breast cancer: when proteomics challenges biological complexity.

Authors:  Hubert Hondermarck
Journal:  Mol Cell Proteomics       Date:  2003-05-29       Impact factor: 5.911

9.  Mutations of the VHL tumour suppressor gene in renal carcinoma.

Authors:  J R Gnarra; K Tory; Y Weng; L Schmidt; M H Wei; H Li; F Latif; S Liu; F Chen; F M Duh
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

Review 10.  Comparing protein abundance and mRNA expression levels on a genomic scale.

Authors:  Dov Greenbaum; Christopher Colangelo; Kenneth Williams; Mark Gerstein
Journal:  Genome Biol       Date:  2003-08-29       Impact factor: 13.583

View more
  4 in total

Review 1.  Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluids.

Authors:  Chaochao Wu; Jicheng Duan; Tao Liu; Richard D Smith; Wei-Jun Qian
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-01-12       Impact factor: 3.205

2.  Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells.

Authors:  Joanna Kopecka; Ivana Campia; Andrea Jacobs; Andreas P Frei; Dario Ghigo; Bernd Wollscheid; Chiara Riganti
Journal:  Oncotarget       Date:  2015-03-30

Review 3.  A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.

Authors:  Sara S Faria; Carlos F M Morris; Adriano R Silva; Micaella P Fonseca; Patrice Forget; Mariana S Castro; Wagner Fontes
Journal:  Front Oncol       Date:  2017-02-20       Impact factor: 6.244

4.  P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors.

Authors:  Joanna Kopecka; Gregory M Rankin; Iris C Salaroglio; Sally-Ann Poulsen; Chiara Riganti
Journal:  Oncotarget       Date:  2016-12-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.